Purification of Human Pituitary Prolactin For many years it has been known that growth hormone and prolactin from several mammalian species are separate and distinct protein molecules (Lyons & Dixon 1966) . However, human growth hormone (HGH) contains intrinsic prolactin activity which cannot be removed by purification procedures, and so attempts to isolate prolactin by bioassay of human pituitary fractions have resulted in purification of HGH (Lyons et al. 1960 ).
It was not until Friesen and his colleagues developed an immunological method which could distinguish between human prolactin and human growth hormone that it became possible to purify human prolactin ). The method utilized antiserum to sheep prolactin which crossreacted with human prolactin but not with human growth hormone. The human pituitary prolactin isolated by Friesen differed both immunologically and chemically from human growth hormone and possessed a prolactin activity of 30 iu/mg . Isolation of human prolactin with similar properties has also been reported by . The amino acid at the N-terminus of the human prolactin molecule is leucine , but HGH has phenylalanine in this position (Li et al. 1966) .
Isolation of human prolactin from pituitaries is difficult because of the low content of this hormone in the glands compared with growth hormone (Guyda et al. 1971) , and also because of the high prolactin activity which is intrinsic in human growth hormone. Moreover, enzymatic degradation of HGH can result in enhancement of its prolactin activity .
A high concentration of immunoreactive prolactin has been reported in human amniotic fluid , but this hormone has not yet been isolated and characterized chemically. It is immunologically related to human pituitary prolactin, but is not necessarily identical in chemical structure.
Dr Isabel A Forsyth (National Institutefor Research in Dairying, Shinfield, Reading) Bioassay of Prolactin The development of bioassay methods which are sufficiently sensitive to measure prolactin levels in human plasma has played an important part in the study of this hormone in man (Forsyth & Edwards 1972 , Frantz et al. 1972 . The methods all depend on the ability of prolactin to stimulate biochemical activity and 'milk' secretion by lobulo-alveolar mammary tissue in vitro. Endpoints used include histological assessment of the amount of secretion accumulating in the alveolar lumina in mid-pregnant mouse (Kleinberg & Frantz 1971) 
